HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sharon DeMorrow Selected Research

Neuropeptide Y

8/2013Neuropeptide Y inhibits biliary hyperplasia of cholestatic rats by paracrine and autocrine mechanisms.
5/2011Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sharon DeMorrow Research Topics

Disease

20Cholangiocarcinoma
01/2023 - 04/2007
20Neoplasms (Cancer)
01/2023 - 04/2007
18Hepatic Encephalopathy
01/2022 - 03/2011
17Fibrosis (Cirrhosis)
01/2022 - 02/2008
14Liver Diseases (Liver Disease)
01/2023 - 10/2007
13Hyperplasia
01/2022 - 05/2007
12Cholestasis
01/2022 - 09/2007
11Inflammation (Inflammations)
01/2024 - 12/2016
9Acute Liver Failure (Fulminant Hepatic Failure)
01/2020 - 08/2015
7Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 11/2014
7Neuroinflammatory Diseases
12/2019 - 01/2016
4Liver Failure
06/2021 - 12/2014
3Carcinogenesis
01/2023 - 08/2008
2Obesity
01/2022 - 01/2018
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 08/2008
2Nervous System Diseases (Neurological Disorders)
08/2020 - 11/2016
2Necrosis
01/2019 - 08/2011
2Brain Edema (Cerebral Edema)
01/2018 - 08/2015
2Body Weight (Weight, Body)
01/2018 - 08/2009
2Fatty Liver
01/2018 - 04/2017
2Sclerosing Cholangitis
10/2017 - 10/2016
2Disease Progression
01/2017 - 11/2015
2Neurologic Manifestations (Neurological Manifestations)
12/2016 - 12/2014
1Neoplasm Metastasis (Metastasis)
01/2023
1Hyperammonemia
01/2022
1Wounds and Injuries (Trauma)
01/2021
1Hypoxia (Hypoxemia)
01/2021

Drug/Important Bio-Agent (IBA)

13Bile Acids and Salts (Bile Acids)IBA
01/2022 - 06/2014
9AzoxymethaneIBA
01/2020 - 07/2014
8EnzymesIBA
01/2023 - 11/2008
7EndocannabinoidsIBA
01/2023 - 04/2007
7Histamine (Histamine Dihydrochloride)FDA Link
11/2018 - 05/2012
4Transaminases (Aminotransferases)IBA
01/2024 - 08/2011
4CytokinesIBA
01/2022 - 07/2014
4AmmoniaIBA
01/2022 - 01/2017
4CollagenIBA
11/2017 - 08/2011
4NeuropeptidesIBA
04/2017 - 09/2007
4anandamide (arachidonylethanolamide)IBA
07/2011 - 04/2007
3MicroRNAs (MicroRNA)IBA
01/2023 - 12/2007
3LeptinIBA
01/2022 - 08/2008
3ATP-Binding Cassette Sub-Family B Member 4IBA
01/2022 - 11/2017
3Neutralizing AntibodiesIBA
01/2022 - 05/2011
3Transforming Growth Factor beta (TGF-beta)IBA
04/2019 - 10/2016
3Histamine Receptors (Histamine Receptor)IBA
01/2018 - 10/2009
3Hormones (Hormone)IBA
11/2017 - 07/2008
3MelatoninIBA
11/2017 - 11/2014
3Histidine DecarboxylaseIBA
10/2016 - 05/2012
3SecretinFDA Link
11/2014 - 07/2010
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2014 - 10/2009
3Serotonin (5 Hydroxytryptamine)IBA
10/2012 - 11/2008
3Monoamine Oxidase (MAO)IBA
10/2012 - 11/2008
3Messenger RNA (mRNA)IBA
08/2011 - 05/2010
3Proteins (Proteins, Gene)FDA Link
05/2011 - 05/2007
2Leptin ReceptorsIBA
01/2022 - 08/2008
2NitrogenIBA
01/2021 - 12/2016
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2020 - 12/2014
2ChemokinesIBA
10/2019 - 07/2014
2Interleukin-6 (Interleukin 6)IBA
10/2019 - 01/2018
2Thioacetamide (Thioacetamid)IBA
01/2018 - 08/2008
2Carboxy-LyasesIBA
01/2018 - 01/2018
2Histidine (L-Histidine)FDA Link
01/2018 - 01/2018
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2017 - 04/2015
2Arylalkylamine N-AcetyltransferaseIBA
10/2017 - 11/2014
2MorpholinosIBA
04/2017 - 12/2014
2salicylhydroxamic acid (SHAM)IBA
04/2017 - 08/2011
2Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
01/2017 - 08/2009
2Cholestyramine Resin (Questran)FDA LinkGeneric
01/2017 - 02/2016
2Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric
10/2016 - 01/2016
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
02/2016 - 09/2010
2Peptides (Polypeptides)IBA
12/2015 - 04/2015
2Proliferating Cell Nuclear Antigen (PCNA)IBA
05/2014 - 08/2011
2Substance PIBA
05/2014 - 08/2011
2Neuropeptide YIBA
08/2013 - 05/2011
2Adenosine (Adenocard)FDA LinkGeneric
03/2013 - 05/2007
2secretin receptorIBA
03/2013 - 07/2010
2Dopamine (Intropin)FDA LinkGeneric
10/2012 - 05/2010
2Death Domain ReceptorsIBA
07/2011 - 04/2007
2LipidsIBA
07/2011 - 04/2007
2glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA
05/2010 - 04/2007
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2023
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
01/2023
1Glycerol (Glycerine)FDA LinkGeneric
01/2023
1TaurineFDA Link
06/2021
1interleukin-24 (ST16)IBA
01/2021
1CytochromesIBA
01/2021
1Oxygen (Dioxygen)IBA
01/2021
1InterleukinsIBA
01/2021
1Cytochrome P-450 CYP3AIBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
1Thrombospondin 1IBA
01/2020
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2020
1Galanin Receptors (Galanin Receptor)IBA
01/2020
1Ghrelin ReceptorsIBA
01/2020
1GhrelinIBA
01/2020
1Urea (Carbamide)FDA LinkGeneric
12/2019

Therapy/Procedure

8Therapeutics
01/2021 - 06/2007
3Ligation
04/2017 - 07/2010
3Drug Therapy (Chemotherapy)
09/2010 - 11/2008
2Aftercare (After-Treatment)
11/2018 - 05/2011
2Radiotherapy
05/2010 - 11/2008